BNEF: EV Fast Charging More Expensive Than Gasoline in Europe
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 minutes ago
- Yahoo
Tesla Is Ramping Up Its Robotaxi Plans. What Does That Mean for TSLA Stock?
Tesla (TSLA) shares are in focus on Thursday following reports the company is searching for employees for its robotaxi operations in the New York City. The news arrives only days after Elon Musk, the billionaire chief executive of the electric vehicle behemoth, threatened a lawsuit against Apple (AAPL) for antitrust violation. More News from Barchart Why This Cannabis Penny Stock Could Be Wall Street's Next Meme Trade Breakout Apple Stock Is Gaining Momentum, Is AAPL Stock a Buy? Peter Thiel-Backed Bullish Is About to IPO. Should You Buy BLSH Stock? Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market analysis you won't find anywhere else. Tesla stock has been a tale of two cities this year. For those who invested in it in early 2025, it's down nearly 20% at the time of writing, but for ones that hopped on in early April, it's up 50%. Growing Robotaxi Services Could Benefit Tesla Stock TSLA's push to hire robotaxi operators in NYC indicates forward momentum in its autonomous vehicle strategy, an area investors increasingly view as a high-margin, scalable growth engine. More importantly, plans of expanding into one of the world's most complex urban environments signals management's confidence in the company's Full Self-Driving (FSD) technology. Note that Tesla does not currently have regulatory authorization for its robotaxi services in NY, but the news still is a positive for TSLA shares. Why? Because it reinforces the company's commitment to capture future ride-hailing revenue, and its overall stature as a tech innovator, which may boost investor sentiment and speculative value. Guggenheim Warns of a 50% Crash in TSLA Shares CEO Elon Musk has already confirmed Tesla will open its robotaxi services to the public in Austin next month but a senior Guggenheim analyst doubts the company's ability to effectively execute its robotaxi platform. In a research note on Thursday, Ronald Jewsikow cited TSLA's lack of transparency around Safety Monitors for his bearish view on the EV stock. Given that human safety drivers are still present in Tesla's robotaxis, it's well within reason to assume that full autonomy isn't ready, despite investor optimism, he told clients. Guggenheim maintains its 'Sell' rating on Tesla shares with a $175 price target indicating potential downside of about 50% from current levels. Wall Street Remains Dovish on Tesla While note as bearish as Guggenheim, other Wall Street firms aren't particularly positive on TSLA stock either. The consensus rating on Tesla stock currently sits at 'Hold' only with the mean target of roughly $300 suggesting potential downside of some 10% from here. On the date of publication, Wajeeh Khan did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Sign in to access your portfolio
Bloomberg
12 minutes ago
- Bloomberg
Romanian Premier Vows Deeper Spending Cuts to Avoid Default Risk
Romania's new prime minister warned his country could face a default unless the government quickly reins in years of lavish spending. Premier Ilie Bolojan said in an interview with Bloomberg News on Thursday that he sees the next six months as crucial for his administration to impose a series of radical austerity measures despite growing public discontent and tensions within the ruling coalition.
Yahoo
15 minutes ago
- Yahoo
iOS 18.6.1 And watchOS 11.6.1 Launch With Restored Blood Oxygen Feature In The U.S.
A couple of weeks after releasing the iOS 18.6 and watchOS 11.6 updates, Apple has just launched iOS 18.6.1 and watchOS 11.6.1. These new software versions restore the blood oxygen functionality banned from American Apple Watch models due to a legal dispute between Masimo and Apple. By the end of 2023, this legal battle briefly forced Apple to halt Apple Watch Series 9 and Apple Watch Ultra 2 sales. Then, by the beginning of 2024, the company resumed sales of the smartwatches, but without the blood oxygen functionality. More frustrating for users, if they needed to repair an Apple Watch, it would lose support for this previously built-in functionality. In a press release shared earlier this morning, the company announced that these users will now have access to "redesigned blood oxygen features by updating their paired iPhone to iOS 18.6.1 and their Apple Watch to watchOS 11.6.1." According to the company, the captured data will be measured and calculated on the iPhone, with the results available in the Respiratory section of the Health app. Read more: How To Control An iPad With Your iPhone Blood Oxygen's Comeback Is Good News For Future Apple Watch Features While Apple says nothing is changing for those who purchased a newer Apple Watch outside the U.S., it's good to see this functionality making a comeback in one of Apple's most important markets. More than that, restoring blood oxygen support could also lead to other new health features. In a previous report, Bloomberg suggested that Apple plans to add blood pressure monitoring to the Apple Watch Series 11. The device is expected to be unveiled next month alongside the iPhone 17. The blood pressure technology is expected to follow the same path as the blood oxygen and sleep apnea functionalities, where Apple warns users that there might be something wrong depending on the measurements. While the sensors won't have the same FDA approval certificate as the ECG sensor, at least it's going to be something users can check with the watch. Read the original article on BGR.
